Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
Daniel Junker, Alex Dulovic, Matthias Becker, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
Trung Tran, Eline Benno Vaage, Adi Mehta, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 28
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease
Simon Woelfel, Joel Dütschler, Daniel Junker, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 774-774
Open Access | Times Cited: 4
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
Matthias Becker, Anne Cossmann, Karsten Lürken, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
Nicole Roth, Janina Gergen, Kristina Kovacikova, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 318-318
Open Access | Times Cited: 7
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
Daniel Junker, Matthias Becker, Teresa R. Wagner, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e240-e249
Open Access | Times Cited: 11
STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease
Simon Woelfel, Joel Dütschler, Marius König, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 7, pp. 678-691
Closed Access | Times Cited: 6
Differences in the organization of interface residues tunes the stability of the SARS-CoV-2 spike-ACE2 complex
Mattia Miotto, Lorenzo Di Rienzo, Greta Grassmann, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 5
Primary Exposure to SARS-CoV-2 via Infection or Vaccination Determines Mucosal Antibody-Dependent ACE2 Binding Inhibition
Janeri Fröberg, Vera Koomen, Christa E. van der Gaast–de Jongh, et al.
The Journal of Infectious Diseases (2023)
Open Access | Times Cited: 5
Humoral immune response to SARS-CoV-2 and endemic coronaviruses in urban and indigenous children in Colombia
Nathalie V. Fernández Villalobos, Patrick Marsall, Johanna Carolina Torres Páez, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 3
Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates
Günalp Uzun, Rebecca Müller, Karina Althaus, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1357-1357
Open Access | Times Cited: 2
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-based Omicron COVID-19 Vaccination in Small Animal Models
Nicole Roth, Janina Gergen, Kristina Kovacikova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Development and validation of a respiratory syncytial virus multiplex immunoassay
Patrick Marsall, Madeleine Fandrich, Johanna Griesbaum, et al.
Infection (2024) Vol. 52, Iss. 2, pp. 597-609
Open Access
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Diseases
Simon Woelfel, Daniel Junker, Irina Bergamin, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1241-1241
Open Access
Nanoparticle-Supported, Rapid, Digital Quantification of Neutralizing Antibodies Against SARS-CoV-2 Variants
Seyedsina Mirjalili, Md Ashif Ikbal, Ching‐Wen Hou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A novel method for recombinant mammalian‐expressed S‐HBsAg virus‐like particle production for assembly status analysis and improved anti‐HBs serology
Michael Lehky, Tashveen Moonian, Tanja Michel, et al.
Protein Science (2024) Vol. 34, Iss. 1
Open Access
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Claudia Tandler, Jonas S. Heitmann, Tanja Michel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Development and validation of a respiratory syncytial virus multiplex immunoassay
Patrick Marsall, Madeleine Fandrich, Johanna Griesbaum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
Matthias Becker, Anne Cossmann, Karsten Lürken, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top